Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age.
Introduction
Structural atrial remodeling is a well-described phenomenon in patients with atrial fibrillation (AF).
Alterations in atrial structure and function associated with AF are commonly expressed as left atrial enlargement and reduced contractility that are likely to be caused by cardiomyocyte and interstitial changes observed in animal models of AF (1, 2) . Whether fibrotic transformation of atrial myocardium is a cause or consequence of AF in patients with cardiovascular disease remains a matter of debate.
Aging is associated with the risk of developing AF, which has commonly been explained by the agedependent change in cellular electrophysiological properties shown in experiment(3) as well as loss and isolation of atrial myocardium and associated atrial conduction disturbances predisposing to AF (4) .
Recent developments in magnetic-resonance imaging resulted in development of methodology aimed at detecting the presence of atrial fibrosis with delayed enhancement by using extracellular gadolinium-based contrast agents (DE-MRI) (5) . Using this technique, the presence and extent of atrial fibrosis showed an association with AF persistency (6) and is similar in AF patients regardless of any comorbidities, thus suggesting a close pathophysiological link between atrial fibrosis and arrhythmogenesis (7) . However, human histology data that would prove the validity of this concept in clinical settings are scarce. Available reports concern mostly patients with mitral valve disease (8) . A single report (9) on patients with lone AF, reported an association between the presence of fibrosis and the history of AF. Although the association between age, atrial fibrosis extent and development of post-operative AF has been reported in patients undergoing open-heart surgery in several studies (10) (11) (12) those investigations were based on the atrial appendage tissue samples. A systematic qualitative and quantitative study of atrial tissues from both chambers of non-valvular AF is lacking.
In this study, we analyzed the extent of histological abnormalities in the left atrium (LA) and major atrial conduction routes in order to elucidate any correlation between the presence and clinical types of AF, age, and comorbidities.
Material

Study design
Following local ethics approval for medical research, 276 autopsies at the Federal Heart, Blood and Endocrinology Centre (St. Petersburg, Russia) fromJanuary 1, 2009 to June 15, 2010 were reviewed.
In order to minimize selection bias impact, medical records of consecutive cases of in-hospital deaths referred for post-mortem studies were screened for AF presence and clinical type. Patients with AF after open-heart surgery were excluded. We compared three groups of 10 subjects each, all without significant valvular disease: no indication of AF history (NoAF group); history of paroxysmal or repeatedly cardioverted persistent AF (PxAF group); and history of permanent AF with duration of at least one year prior to death (PermAF group).
Tissue sample collection and handling
Transmural atrial tissue samples of at least 20 x 3 mm were collected from five locations that included major atrial conduction pathways and posterior LA region in the vicinity of pulmonary vein ostia ( Figure 1 ). The sites were: crista terminalis at right atrium lateral wall (CT); Bachmann's bundle from the superior portion of the interatrial groove between the atria (BB); posterior LA wall at superior pulmonary veins (SPV) level; centrally between pulmonary vein ostia (PLA); and at inferior pulmonary veins (IPV) level.
Atrial tissue samples were fixed in 10% buffered formalin and embedded in paraffin. Sections (2 µm thick) were cut parallel to the atrial wall plane and stained with Masson's trichrome stain (Figure 2 ). 
Statistical analyses
Data are expressed as the mean ± standard deviation unless stated otherwise. 
Results
Patient characteristics
Clinical characteristics of patients are presented in There was no difference between the groups in regard to pharmacological treatment with ACEinhibitors, angiotensin-2 receptor blockers, beta-blockers, statins or diuretics. Digoxin was commonly used in PermAF patients but not in NoAF or PxAF groups (Table 1) .
Echocardiographic data were available for 21 patients (16 AF and 5 NoAF patients) and concerned examinations performed during these patients' last hospital admission. LA diameter measured in parasternal view was significantly larger in patients with AF history (52±11 vs 40±5 mm, p=0.039)
while there was no difference in left ventricular ejection fraction (39±15 vs 40±14 %, p=0.802).
Medical record information on AF history duration was available for 18 patients (median 24 months, range 0.5-192 months). The remaining two patients presented with PxAF with unknown time of symptom onset.
Site-dependent histological abnormalities
The extent of fibrosis, fatty infiltration, capillary density and cardiomyocyte size did not differ among the five sampling locations in the atria, neither in total material nor in subgroup analysis (data not shown).
Possible correlation between fibrosis and any other histological variable was assessed at all five locations. The extent of fibrosis demonstrated weak positive correlation with the mean cardiomyocyte diameter at BB (r=0.589, p=0.001), IPV (r=0.459, p=0.011) and PLA (r=0.453, p=0.012) locations. We observed no significant correlation between the extent of fibrosis and capillary density at any location. In PLA, the extent of fibrosis showed significant positive correlation with the extent of fatty infiltration (r=0.439, p=0.015) but at all other locations no such association was observed(data not shown).
The extent of fibrosis positively correlated with CD3-and CD45-positive leucocyte count at BB (r=0.75, p<0.001 for CD3 and r=0.67, p<0.001 for CD45) and PLA (r=0.76, p<0.001 for CD3 and r=0.67, p<0.001 for CD45), but not at CT.
Atrial fibrillation history
Patients with any history of AF had a three-to five-fold greater extent of fibrosis and fatty tissue compared to patients without AF history, regardless of tissue sampling location (Table 2) . Similarly, a strong association between inflammatory cell count and AF history was observed at all tissue sampling locations where inflammatory response was assessed (Table 3) . However, neither capillary density nor mean cardiomyocyte diameter showed any notable difference among the groups in regard to the AF history.
A three-group comparison revealed generally greater extent of fibrosis in patients with PermAF compared with PxAF patients that passed the significance threshold for BB and SPV locations ( Figure   3 ). This phenomenon, however, was not observed when the extent of fatty tissue was compared.
The extent of fibrosis alone showed borderline significance for correlation with AF history duration at IPV (r=0.466, p=0.05), but not at any other location. The correlation of combined count for fibrosis and fatty infiltration and AF history duration at IPV was stronger than for fibrosis alone (r=0.675, p=0.002). AF history duration also showed positive correlation with cardiomyocyte diameter that reached significance at BB location (r=0.542, p=0.02). 
Left atrial diameter
Age and gender
No gender-related associations were observed for any histology parameter.
No increase in atrial fibrosis associated with higher age was observed either in total material or in patient subgroups with or without AF history ( Figure 3) .
None of the histology parameters, including fibrosis, showed any significant correlation with age in either subgroups or total material (data not shown) using Spearman's correlation.
Discussion
Our study carried out in a systematic fashion provides histological evidence of robust association between extent of structural changes in left atrial walls and major atrial conduction pathways with AF history and clinical type. Patients with permanent AF consistently had more extensive fibro-fatty replacement of atrial myocardium than patients with paroxysmal AF and otherwise similar clinical profile. On the contrary, despite the wide age range and the presence of comorbidities likely to contribute to fibrosis development in all three groups, we were not able to detect any correlation between patient age and increase in the extent of fibrosis or fatty changes in atrial tissue, in either total material or subgroup analyses.
Previous studies
Human data on association between the extent of structural atrial changes and the presence of lone AF are scarce. In one study (9) , the presence of patchy fibrosis along with widespread inflammatory changes was observed in atrial septal biopsies taken from patients with lone AF but not in those without AF history. However, it was unclear whether AF in patients with cardiovascular disease would demonstrate a similarly strong association between fibrosis and arrhythmia or whether structural abnormalities confined to the atrial septum were also present in other parts of atria. Our study of non-valvular AF in patients with comorbidities commonly associated with development of AF, i.e. mainly ischemic heart disease and hypertension, is relevant to the vast majority of AF patients heart surgery and reported 10.8%±11% fibrosis extent in patients who developed postoperative AF compared with 3.8% ± 3.5% in those remaining in normal sinus rhythm. The authors also reported more fibrosis in left atrium compared with right atrium, but the finding is not supported by our study.
In a study by Goette et al. (10) , fibrosis extent in right atrial appendage was significantly associated with both age and AF incidence in post-operative period, thus supporting the causative role of agerelated fibrosis in post-operative AF. The discrepancy can be explained by significant differences between postoperative AF in the Swartz et al.(11) study, whereas AF was remote from open heart surgery in our cases.
Our finding of a strong association between fibrosis extent and inflammatory cell count in patients with AF history is in agreement with earlier reports (14, 15) and further supports the important role inflammation plays in creation of an AF substrate. We demonstrated the presence of inflammatory infiltrate in major atrial pathways (CT and BB) and in posterior LA wall in patients with AF, and documented its association with LA dilatation.
Fibrosis in atrial fibrillation: cause or consequence?
Recent developments in imaging and the introduction of delayed enhancement technology provided indirect evidence of fibrosis in the left atrium associated with the presence of AF regardless of comorbidities(7). In another study, DE-MRI revealed that patients with persistent AF compared with paroxysmal AF showed more fibrosis in the left atrium (16) . Our study is in agreement with these observations and provides direct histological evidence of pathophysiological association between extent of fibro-fatty atrial abnormalities and AF presence and persistency.
Our study results, however, do not answer the question of whether the fibro-fatty replacement of atrial myocardium associated with AF presence is the cause or the consequence of the arrhythmia.
The patients in our study could have developed the observed structural alterations as a result of more or less long-standing AF, and, if so, the changes we observed truly represent structural atrial Experimental data comparing AF promoted by rapid atrial pacing and the development of congestive heart failure in dogs suggest that atrial pacing-induced atrial fibrillation in the absence of congestive heart failure per se does not promote development of fibrosis(1). Our findings in humans contradict these experimental data. First, we were not able to detect any link between the extent of fibrosis and left ventricular ejection fraction, while the significant association between LA size and structural abnormalities mostly confined to LA was rather an expected finding. Second, atrial samples taken from age-matched arrhythmia-free patients contained negligibly low amounts of fibro-fatty tissue despite similar clinical profile and the presence of congestive heart failure, ischemic heart disease or hypertension in the majority of subjects in all three groups. It cannot be completely ruled out that patients without AF history in our study had less severe clinical manifestations of accompanying conditions leading to less advanced atrial structural changes that could not be reliably evaluated in a retrospective journal-based analysis. Nevertheless, patients with permanent AF in our study had significantly more extensive structural atrial abnormalities than patients with paroxysmal AF associated with AF history duration.
Structural abnormalities of major conduction pathways
We have demonstrated not only the presence of fibro-fatty replacement of atrial myocardium in the left atrium recently linked to the effect of catheter ablation (7) but we also analyzed the extent of structural abnormalities in major atrial conduction pathways namely Bachmann's bundle and crista terminalis. Deteriorated atrial conduction in patients with paroxysmal AF has been well-documented in electrocardiographic (21, 22) and invasive electrophysiological studies (23, 24) . In a recent study on patients enrolled in the MADIT-II trial, we have shown that abnormal atrial conduction bears an independent predictive value for developing new onset AF in patients with ischemic heart failure, thus supporting the primary role of conduction defects in developing AF in this patient population (25) . Although the possibility of strategically located structural atrial abnormalities affecting Bachmann's bundle and terminal crest was reported in an earlier study by Becker et al. on both valvular and non-valvular AF (26) , our study provides a morphometric analysis of these changes and suggests that the changes are likely to represent a manifestation of a generalized pathological process affecting left and right atria equally.
Lack of age-related increase in extent of structural changes
Although association between age and atrial fibrosis has become conventional wisdom, and "agerelated fibrosis" is listed as one of the etiological factors underlying AF development in management guidelines(4), analyses of atrial wall histology, with few exceptions(9)(8), were mostly performed on patients undergoing open heart surgery without prior history of AF (10, 11, 13) . AF prevalence has been clearly shown to increase with age (27, 28) ; however, whether the increase was due to extensive atrial fibrosis has not been convincingly demonstrated. In a recent report, right atrial appendage biopsies taken during open-heart surgery in patients without AF history revealed positive correlation between fibrosis extent and age (13) . Our study found no such correlation in a similar age span (although smaller) population which suggests that age-related increase in fibrosis extent does not reach the magnitude of changes observed in AF. We propose that age contribution to fibrosis development is limited and unlikely to be the sole explanation of advanced fibrosis observed in AF patients.
Limitations
We had to rely on medical record data without possibility of additional investigations in order to resolve uncertainties or verify AF diagnosis. For the same reason, echocardiographic variables are limited to left ventricular ejection fraction and LA diameter as other measurements relevant in the context of atrial remodeling, including left ventricular diastolic function assessment, were not consistently reported in all subjects. Finally, the small number of cases might lead to possible underestimation of age effect on structural changes of atrial walls but we believe our detailed histological analysis could mitigate that.
Conclusion
In post-mortem atrial tissues from patients who died of cardiovascular causes, the extent of fibrosis was not associated with age, but was significantly correlated with AF presence, severity and duration.
Chronic inflammation in atrial myocardium is likely to play an important role this process. Our findings suggest that age-related changes per se are unlikely to be the sole cause of advanced fibrosis underlying AF. 
